Prognosis
Botswana Approves Corbevax Covid Vaccine, Plans Local Output
- Biotech billionaire Soon-Shiong speaks at launch in Botswana
- Soon-Shiong plans to build vaccine plant in the country
This article is for subscribers only.
Corbevax, a Covid-19 vaccine developed in Texas, has been approved for use in Botswana, according to U.S. biotech billionaire Patrick Soon-Shiong.
Doses of the vaccine currently in production have been reserved for the country, he said at a ceremony on Monday in the southern African nation’s capital, Gaborone. It will ultimately be made at a local factory called Pula Corbevax, Botswanan President Mokgweetsi Masisi said.